Erratum to: Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody (Cardiovascular Drugs and Therapy, 10.1007/s10557-013-6502-9);Memory T cells mediate cardiac allograft vasculopathy and are inactivated by Anti-OX40L monoclonal antibody

Cardiovascular Drugs and Therapy

Volumn 28, Issue 2, 2014, Pages 115-122

  Wang, Hao ^a   Zhang, Zhixiang ^a   Tian, Weijun ^a   Liu, Tong ^a   Han, Hongqiu ^a   Garcia, Bertha ^b   Li, Xian C ^c   Du, Caigan ^d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti OX40L antibody therapy; Cardiac allograft vasculopathy; Heart transplantation; Memory T cell; OX40 pathway

Indexed keywords

CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; HERMES ANTIGEN; L SELECTIN; MESSENGER RNA; MONOCLONAL ANTIBODY; OX40 LIGAND; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ALLOGRAFTS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; HEART TRANSPLANTATION; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; L-SELECTIN; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, OX40; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 84897061290     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-014-6515-z     Document Type: Erratum

References (54)

1. Murphy L, Pinney SP. Clinical outcomes following heart transplantation. Mt Sinai J Med. 2012;79(3):317-29.
2. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant. 2007;26(8):769-81.
3. Gaudin PB, Rayburn BK, Hutchins GM, Kasper EK, Baughman KL, Goodman SN, et al. Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol. 1994;18(4):338-46.
4. Rahmani M, Cruz RP, Granville DJ, McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res. 2006;99(8):801-15.
5. Ramzy D, Rao V, Brahm J, Miriuka S, Delgado D, Ross HJ. Cardiac allograft vasculopathy: a review. Can J Surg. 2005;48(4):319-27.
6. Eisen H, Ross H. Optimizing the immunosuppressive regimen in heart transplantation. J Heart Lung Transplant. 2004;23(5 Suppl):S207-13.
7. Kurtulus S, Tripathi P, Hildeman DA. Protecting and rescuing the effectors: roles of differentiation and survival in the control of memory T cell development. Front Immunol. 2012;3:404.
8. van Loosdregt J, van Oosterhout MF, Bruggink AH, van Wichen DF, van Kuik J, de Koning E, et al. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation. 2006;114(15):1599- 607.
9. Hagemeijer MC, van Oosterhout MF, van Wichen DF, van Kuik J, Siera-de Koning E, Gmelig Meyling FH, et al. T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population. Am J Transplant. 2008;8(5):1040-50.
10. Brook MO, Wood KJ, Jones ND. The impact of memory T cells on rejection and the induction of tolerance. Transplantation. 2006;82(1):1-9.
11. Calderhead DM, Buhlmann JE, van den Eertwegh AJ, Claassen E, Noelle RJ, Fell HP. Cloning of mouse OX40: a T cell activation marker that may mediate T-B cell interactions. J Immunol. 1993;151(10):5261-71.
12. + T cells with homology to tumor necrosis factor. J Exp Med. 1994;180(2):757-62.
13. So T, Lee SW, Croft M. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev. 2008;19(3-4):253-62.
14. + Th cell antitumor immunity in mice. J Clin Invest. 2007;117(11):3330-8.
15. + T cells via OX40-OX40 ligand interactions. J Immunol. 2004;173(6):3716-24.
16. Baumann R, Yousefi S, Simon D, Russmann S, Mueller C, Simon HU. Functional expression of CD134 by neutrophils. Eur J Immunol. 2004;34(8):2268-75.
17. Stuber E, Strober W. The T cell B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med. 1996;183(3):979-89.
18. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol. 2010;28:57-78.
19. Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, Croft M. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol. 2000;165(6):3043-50.
20. Croft M, So T, Duan W, Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev. 2009;229(1):173-91.
21. Ishii N, Takahashi T, Soroosh P, Sugamura K. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63-98.
22. Salek-Ardakani S, Croft M. Regulation of CD4 T cell memory by OX40 (CD134). Vaccine. 2006;24(7):872-83.
23. + T cells. J Immunol. 2007;179(8):5014-23.
24. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68(5):869-77.
25. Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant. 2005;5(3):465-74.
26. Valujskikh A, Lakkis FG. In remembrance of things past: memory T cells and transplant rejection. Immunol Rev. 2003;196:65-74.
27. + cells. J Exp Med. 2002;195(12):1523-32.
28. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med. 2000;192(4):557-64.
29. Murali-Krishna K, Ahmed R. Cutting edge: naive T cells masquerading as memory cells. J Immunol. 2000;165(4):1733-7.
30. Shimizu K, Schonbeck U, Mach F, Libby P, Mitchell RN. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol. 2000;165(6):3506-18.
31. Wu Z, Wang Y, Gao F, Shen X, Zhai Y, Kupiec-Weglinski JW. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients. J Immunol. 2008;181(2):1096-102.
32. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol. 2002;169(8):4667-73.
33. Olfert ED, Cross BM, McWilliam AA. Responsibility for the care and use of experimental animals. In: Olfert ED, Cross BM, McWilliam AA, editors. Guide to the care and use of experimental animals (Vol 1). Ottawa: Association of Universities and Colleges of Canada; 1993. p. 1-14.
34. Wang H, Arp J, Liu W, Faas SJ, Jiang J, Gies DR, et al. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation. J Immunol. 2007;179(7):4451-63.
35. Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B, et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol. 2003;171(7):3823-36.
36. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant. 2004;4(10):1562-6.
37. Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol. 2006;176(3):1394-401.
38. Gerberick GF, Cruse LW, Miller CM, Sikorski EE, Ridder GM. Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol. 1997;146(1):1-10.
39. Nakano M, Fukumoto Y, Satoh K, Ito Y, Kagaya Y, Ishii N, et al. Genetic Deletion of Ox40 Ligand Suppresses the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice. J Vasc Res. 2009;46:100.
40. + T cells in neonatal mice allows the generation of long-lived natural memory T cells. J Immunol. 2004;172(1):15-9.
41. Zhang P, Manes TD, Pober JS, Tellides G. Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells. Arterioscler Thromb Vasc Biol. 2010;30(9):1795-801.
42. Ge W, Jiang J, Liu W, Lian D, Saito A, Garcia B, et al. Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells. Am J Transplant. 2010;10(8):1760-73.
43. + T cells. J Exp Med. 1997;186(9):1407-18.
44. + memory T cells. J Exp Med. 1997;186(6):859-65.
45. Zimmermann C, Prevost-Blondel A, Blaser C, Pircher H. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur J Immunol. 1999;29(1):284-90.
46. + T cells: effector T cells. Int Immunol. 1998;10(12):1837-45.
47. Huibers M, De Jonge N, Van Kuik J, Koning ES, Van Wichen D, Dullens H, et al. Intimal fibrosis in human cardiac allograft vasculopathy. Transpl Immunol. 2011;25(2-3):124-32.
48. Wang Y, Bai Y, Qin L, Zhang P, Yi T, Teesdale SA, et al. Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res. 2007;101(6):560-9.
49. Tellides G, Pober JS. Interferon-gamma axis in graft arteriosclerosis. Circ Res. 2007;100(5):622-32.
50. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403(6766):207-11.
51. Kirkiles-Smith NC, Tereb DA, Kim RW, McNiff JM, Schechner JS, Lorber MI, et al. Human TNF can induce nonspecific inflammatory and human immune-mediated microvascular injury of pig skin xenografts in immunodeficient mouse hosts. J Immunol. 2000;164(12):6601-9.
52. + T cell survival in the transition phase. Biochem Biophys Res Commun. 2007;360(3):702-7.
53. Davis R, Pillai S, Lawrence N, Sebti S, Chellappan SP. TNF-alpha-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes. Cell Cycle. 2012;11(1):109-18.
54. Carter LL, Zhang X, Dubey C, Rogers P, Tsui L, Swain SL. Regulation of T cell subsets from naive to memory. J Immunother. 1998;21(3):181-7.